longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Clover Health Investments

CLOV

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -131.91, below the reasonable range, cheaper than 99.31% of the time in the past 5 years, and the industry ranks 8/9, the industry Median 23.85.

-131.91xP/E
$4.56Stock price
$-0.03Earnings per share
-131.91xP/E
Stock price$4.56Earnings per share$-0.03

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-3.63x
Typical range
-30.44x–-1.83x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.85x
010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.85x
0x10x20x30x40x50x
P/E ratio
Name/Symbol
CNCUSCentene
-6.39x128.36%$32.61B
MOHUSMolina Healthcare
-1,507.98x66.98%$10.56B
CLOVUSClover Health Investments
-131.91x133.21%$2.42B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.